Pharmacokinetics of hydroxychloroquine and its clinical implications in chemoprophylaxis against malaria caused by Plasmodium vivax.

PubWeight™: 1.04‹?› | Rank: Top 15%

🔗 View Article (PMC 2663072)

Published in Antimicrob Agents Chemother on February 02, 2009

Authors

Hyeong-Seok Lim1, Jeong-Soo Im, Joo-Youn Cho, Kyun-Seop Bae, Terry A Klein, Joon-Sup Yeom, Tae-Seon Kim, Jae-Seon Choi, In-Jin Jang, Jae-Won Park

Author Affiliations

1: Department of Pharmacology, Ulsan University College of Medicine, Songpa-gu, Seoul, Republic of Korea.

Associated clinical trials:

Will Hydroxychloroquine Impede or Prevent COVID-19 (WHIP COVID-19) | NCT04341441

Articles citing this

A phase I/II trial of hydroxychloroquine in conjunction with radiation therapy and concurrent and adjuvant temozolomide in patients with newly diagnosed glioblastoma multiforme. Autophagy (2014) 1.85

Phase I trial of hydroxychloroquine with dose-intense temozolomide in patients with advanced solid tumors and melanoma. Autophagy (2014) 1.77

Plasmodium vivax malaria: status in the Republic of Korea following reemergence. Korean J Parasitol (2009) 1.51

Phase I clinical trial and pharmacodynamic evaluation of combination hydroxychloroquine and doxorubicin treatment in pet dogs treated for spontaneously occurring lymphoma. Autophagy (2014) 1.29

Autophagy inhibition for chemosensitization and radiosensitization in cancer: do the preclinical data support this therapeutic strategy? J Pharmacol Exp Ther (2013) 1.24

Therapy and pharmacological properties of hydroxychloroquine and chloroquine in treatment of systemic lupus erythematosus, rheumatoid arthritis and related diseases. Inflammopharmacology (2015) 0.89

Chloroquine interference with hemoglobin endocytic trafficking suppresses adaptive heme and iron homeostasis in macrophages: the paradox of an antimalarial agent. Oxid Med Cell Longev (2013) 0.77

Distribution of malaria vectors and incidence of vivax malaria at Korean army installations near the demilitarized zone, Republic of Korea. Malar J (2016) 0.75

Novel Therapies for Myocardial Irritability following Extreme Hydroxychloroquine Toxicity. Case Rep Emerg Med (2015) 0.75

Articles cited by this

[''R"--project for statistical computing]. Ugeskr Laeger (2008) 41.69

The economic and social burden of malaria. Nature (2002) 14.20

Plasmodium falciparum: in vitro studies of the pharmacodynamic properties of drugs used for the treatment of severe malaria. Exp Parasitol (1993) 4.98

Chloroquine resistance in Plasmodium vivax. Antimicrob Agents Chemother (2004) 4.54

Plasmodium vivax resistance to chloroquine? Lancet (1989) 4.51

Inhibition by chloroquine of a novel haem polymerase enzyme activity in malaria trophozoites. Nature (1992) 3.67

Malaria in Korea. Jpn J Exp Med (1988) 2.93

Pharmacokinetics of quinine, chloroquine and amodiaquine. Clinical implications. Clin Pharmacokinet (1996) 2.33

Vivax malaria resistant to treatment and prophylaxis with chloroquine. Lancet (1993) 2.23

Vivax malaria: a continuing health threat to the Republic of Korea. Am J Trop Med Hyg (2003) 1.85

Plasmodium vivax: Merozoites, invasion of reticulocytes and considerations for malaria vaccine development. Parasitol Today (1996) 1.84

Korean vivax malaria. I. Natural history and response to chloroquine. Am J Trop Med Hyg (1953) 1.75

Status of Plasmodium vivax malaria in the Republic of Korea during 2001-2003. Am J Trop Med Hyg (2005) 1.51

Enantioselective disposition of hydroxychloroquine after a single oral dose of the racemate to healthy subjects. Br J Clin Pharmacol (1995) 1.43

On the question of dose-dependent chloroquine elimination of a single oral dose. Clin Pharmacol Ther (1983) 1.34

Plasmodium vivax malaria in the Republic of Korea during 2004-2005: changing patterns of infection. Am J Trop Med Hyg (2007) 1.30

Ethnic or racial differences revisited: impact of dosage regimen and dosage form on pharmacokinetics and pharmacodynamics. Clin Pharmacokinet (2006) 1.29

Population pharmacokinetics of hydroxychloroquine in patients with rheumatoid arthritis. Ther Drug Monit (2003) 1.19

Evaluation of anti-malarial effects of mass chemoprophylaxis in the Republic of Korea army. J Korean Med Sci (2005) 1.13

Pharmacokinetics of chloroquine in Thais: plasma and red-cell concentrations following an intravenous infusion to healthy subjects and patients with Plasmodium vivax malaria. Br J Clin Pharmacol (1988) 1.11

Detection and prevention of maculopathy associated with antimalarial agents. Int Ophthalmol Clin (1999) 1.08

Antimalarial activity of the optical isomers of chloroquine diphosphate. Tropenmed Parasitol (1979) 1.08

Concentration-effect relationship of hydroxychloroquine in rheumatoid arthritis--a cross sectional study. J Rheumatol (1993) 1.04

Apparent dose-dependence of chloroquine pharmacokinetics due to limited assay sensitivity and short sampling times. Eur J Clin Pharmacol (1987) 1.00

Recent developments in the understanding of the pharmacokinetics and mechanism of action of chloroquine. Ther Drug Monit (1989) 0.99

Pharmacokinetic comparison of an angiotensin II receptor antagonist, telmisartan, in Japanese and western hypertensive patients using population pharmacokinetic method. Drug Metab Pharmacokinet (2004) 0.90

Studies of the metabolism of some compounds of the 4-amino-7-chloroquinoline series. J Pharmacol Exp Ther (1966) 0.88

Disposition of the enantiomers of hydroxychloroquine in patients with rheumatoid arthritis following multiple doses of the racemate. Br J Clin Pharmacol (1993) 0.87

B-hematin. Biochem Mol Biol Int (1995) 0.78

Articles by these authors

Clinical implications of CYP2D6 genotypes predictive of tamoxifen pharmacokinetics in metastatic breast cancer. J Clin Oncol (2007) 2.71

Comprehensive analysis of UGT1A polymorphisms predictive for pharmacokinetics and treatment outcome in patients with non-small-cell lung cancer treated with irinotecan and cisplatin. J Clin Oncol (2006) 2.69

Spread of methicillin-resistant Staphylococcus aureus between the community and the hospitals in Asian countries: an ANSORP study. J Antimicrob Chemother (2011) 2.30

Increased risk of atherothrombotic events associated with cytochrome P450 3A5 polymorphism in patients taking clopidogrel. CMAJ (2006) 2.01

Vivax malaria: a continuing health threat to the Republic of Korea. Am J Trop Med Hyg (2003) 1.85

Soochong virus: an antigenically and genetically distinct hantavirus isolated from Apodemus peninsulae in Korea. J Med Virol (2006) 1.83

The effect of therapeutic drug monitoring on safety and efficacy of voriconazole in invasive fungal infections: a randomized controlled trial. Clin Infect Dis (2012) 1.76

Tick-borne rickettsial pathogens in ticks and small mammals in Korea. Appl Environ Microbiol (2006) 1.74

Characterization of Imjin virus, a newly isolated hantavirus from the Ussuri white-toothed shrew (Crocidura lasiura). J Virol (2009) 1.68

Clinical impact of methicillin resistance on outcome of patients with Staphylococcus aureus infection: a stratified analysis according to underlying diseases and sites of infection in a large prospective cohort. J Infect (2010) 1.63

Liver cirrhosis as a risk factor for mortality in a national cohort of patients with bacteremia. J Infect (2011) 1.60

Short report: chloroquine-resistant Plasmodium vivax in the Republic of Korea. Am J Trop Med Hyg (2009) 1.57

Geographical distribution and relative abundance of vectors of scrub typhus in the Republic of Korea. Korean J Parasitol (2009) 1.56

Dissemination of ST131 and ST393 community-onset, ciprofloxacin-resistant Escherichia coli clones causing urinary tract infections in Korea. J Infect (2009) 1.52

Status of Plasmodium vivax malaria in the Republic of Korea during 2001-2003. Am J Trop Med Hyg (2005) 1.51

Plasmodium vivax malaria: status in the Republic of Korea following reemergence. Korean J Parasitol (2009) 1.51

Factors associated with the success rate of orthodontic miniscrews placed in the upper and lower posterior buccal region. Angle Orthod (2008) 1.47

Endemic Venezuelan equine encephalitis in northern Peru. Emerg Infect Dis (2004) 1.47

Microbial pathogens in ticks, rodents and a shrew in northern Gyeonggi-do near the DMZ, Korea. J Vet Sci (2008) 1.43

Anopheles kleini, Anopheles pullus, and Anopheles sinensis: potential vectors of Plasmodium vivax in the Republic of Korea. J Med Entomol (2007) 1.43

Report of two cases of vivax malaria in U.S. soldiers and a review of malaria in the Republic of Korea. MSMR (2014) 1.41

Predominance of an ST11 extended-spectrum beta-lactamase-producing Klebsiella pneumoniae clone causing bacteraemia and urinary tract infections in Korea. J Med Microbiol (2010) 1.41

A haplotype-based molecular analysis of CFTR mutations associated with respiratory and pancreatic diseases. Hum Mol Genet (2003) 1.40

Detection of Bartonella species from ticks, mites and small mammals in Korea. J Vet Sci (2005) 1.39

Endemic eastern equine encephalitis in the Amazon region of Peru. Am J Trop Med Hyg (2007) 1.38

Emergence of Japanese encephalitis virus genotype V in the Republic of Korea. Virol J (2011) 1.35

Effect of OATP1B1 (SLCO1B1) variant alleles on the pharmacokinetics of pitavastatin in healthy volunteers. Clin Pharmacol Ther (2005) 1.35

Safety, tolerability and pharmacokinetics of udenafil, a novel PDE-5 inhibitor, in healthy young Korean subjects. Br J Clin Pharmacol (2008) 1.33

Risk factors and treatment outcomes of community-onset bacteraemia caused by extended-spectrum beta-lactamase-producing Escherichia coli. Int J Antimicrob Agents (2010) 1.32

Prevalence of tick-borne encephalitis virus in ticks from southern Korea. J Vet Sci (2010) 1.30

Plasmodium vivax malaria in the Republic of Korea during 2004-2005: changing patterns of infection. Am J Trop Med Hyg (2007) 1.30

Muju virus, a novel hantavirus harboured by the arvicolid rodent Myodes regulus in Korea. J Gen Virol (2007) 1.24

MRP2 haplotypes confer differential susceptibility to toxic liver injury. Pharmacogenet Genomics (2007) 1.23

Serosurveillance of scrub typhus in small mammals collected from military training sites near the DMZ, Northern Gyeonggi-do, Korea, and analysis of the relative abundance of chiggers from mammals examined. Korean J Parasitol (2010) 1.22

Resurgence of Plasmodium vivax malaria in the Republic of Korea during 2006-2007. Am J Trop Med Hyg (2009) 1.21

Pharmacokinetics and pharmacodynamics of propofol microemulsion and lipid emulsion after an intravenous bolus and variable rate infusion. Anesthesiology (2007) 1.21

Effect of CYP2C19 polymorphism on the pharmacokinetics of voriconazole after single and multiple doses in healthy volunteers. J Clin Pharmacol (2012) 1.19

Molecular detection of Anaplasma, Bartonella, and Borrelia species in ticks collected from migratory birds from Hong-do Island, Republic of Korea. Vector Borne Zoonotic Dis (2013) 1.17

Prevalence of osteoporosis and reference data for lumbar spine and hip bone mineral density in a Korean population. J Bone Miner Metab (2008) 1.17

Magnetic separation: a highly effective method for synchronization of cultured erythrocytic Plasmodium falciparum. Parasitol Res (2008) 1.15

Prevalence and characterization of extended-spectrum beta-lactamase-producing Enterobacteriaceae isolated in Korean hospitals. Diagn Microbiol Infect Dis (2008) 1.14

Positive and negative associations of HLA class I alleles with allopurinol-induced SCARs in Koreans. Pharmacogenet Genomics (2011) 1.14

Evaluation of anti-malarial effects of mass chemoprophylaxis in the Republic of Korea army. J Korean Med Sci (2005) 1.13

Molecular epidemiological study for tick-borne disease (Ehrlichia and Anaplasma spp.) surveillance at selected U.S. military training sites/installations in Korea. Ann N Y Acad Sci (2003) 1.12

Plagiorchis muris infection in Apodemus agrarius from northern Gyeonggi-do (Province) near the demilitarized zone. Korean J Parasitol (2007) 1.11

Hemorrhagic fever with renal syndrome in 4 US soldiers, South Korea, 2005. Emerg Infect Dis (2009) 1.10

Ticks collected from selected mammalian hosts surveyed in the Republic of Korea during 2008-2009. Korean J Parasitol (2011) 1.10

Seasonal distribution of ticks in four habitats near the demilitarized zone, Gyeonggi-do (Province), Republic of Korea. Korean J Parasitol (2013) 1.09

Evaluation of intravenous midazolam limited sampling models to determine area under the concentration time curve during cytochrome P450 3A baseline, inhibition and induction or activation. Int J Clin Pharmacol Ther (2012) 1.09

Geographic distribution and ecology of potential malaria vectors in the Republic of Korea. J Med Entomol (2009) 1.08

Effect of the CYP3A5 genotype on the pharmacokinetics of intravenous midazolam during inhibited and induced metabolic states. Clin Pharmacol Ther (2004) 1.08

Species composition, larval habitats, seasonal occurrence and distribution of potential malaria vectors and associated species of Anopheles (Diptera: Culicidae) from the Republic of Korea. Malar J (2010) 1.07

Serological surveillance of scrub typhus, murine typhus, and leptospirosis in small mammals captured at firing points 10 and 60, Gyeonggi province, Republic of Korea, 2001-2005. Vector Borne Zoonotic Dis (2010) 1.06

Molecular detection and genotyping of Japanese encephalitis virus in mosquitoes during a 2010 outbreak in the Republic of Korea. PLoS One (2013) 1.06

Evaluation of a rapid diagnostic test specific for Plasmodium vivax. Trop Med Int Health (2008) 1.05

Effect of the UGT2B15 genotype on the pharmacokinetics, pharmacodynamics, and drug interactions of intravenous lorazepam in healthy volunteers. Clin Pharmacol Ther (2005) 1.04

Laboratory transmission of Japanese encephalitis, West Nile, and Getah viruses by mosquitoes (Diptera: Culicidae) collected near Camp Greaves, Gyeonggi Province, Republic of Korea 2003. J Med Entomol (2006) 1.04

Apodemus agrarius as a new definitive host for Neodiplostomum seoulense. Korean J Parasitol (2007) 1.04

Ecological surveillance of small mammals at Firing Points 10 and 60, Gyeonggi Province, Republic of Korea, 2001-2005. J Vector Ecol (2008) 1.03

Humoral responses against the C-terminal region of merozoite surface protein 1 can be remembered for more than 30 years in persons exposed to Plasmodium vivax. Parasitol Res (2004) 1.02

Capacity-building efforts by the AFHSC-GEIS program. BMC Public Health (2011) 1.02

A comparison of ketamine and lidocaine spray with propofol for the insertion of laryngeal mask airway in children: a double-blinded randomized trial. Anesth Analg (2002) 1.01

Voriconazole-associated severe hyponatremia. Med Mycol (2011) 1.00

Japanese encephalitis virus in culicine mosquitoes (Diptera: Culicidae) collected at Daeseongdong, a village in the demilitarized zone of the Republic of Korea. J Med Entomol (2011) 1.00

Seasonal abundance of biting midges, Culicoides spp. (Diptera: Ceratopogonidae), collected at cowsheds in the southern part of the Republic of Korea. Korean J Parasitol (2012) 1.00

Echinostome infections in the striped-field mouse, Apodemus agrarius, and the Ussuri white-toothed shrew, Crocidura lasiura, caught near the demilitarized zone, Gyeonggi-do (Province), Republic of Korea. Korean J Parasitol (2009) 1.00

The relationship between mosquito abundance and rice field density in the Republic of Korea. Int J Health Geogr (2010) 1.00

Haplotype structure and allele frequencies of CYP2B6 in a Korean population. Drug Metab Dispos (2004) 0.99

Ecological niche modeling to estimate the distribution of Japanese encephalitis virus in Asia. PLoS Negl Trop Dis (2012) 0.99

Distribution and larval habitat characteristics of Anopheles Hyrcanus group and related mosquito species (Diptera: Culicidae) in South Korea. J Vector Ecol (2006) 0.99

Pharmacokinetic and pharmacodynamic evaluation of a novel proton pump inhibitor, YH1885, in healthy volunteers. J Clin Pharmacol (2004) 0.99

Malaria in the Republic of Korea, 1993-2007. Variables related to re-emergence and persistence of Plasmodium vivax among Korean populations and U.S. forces in Korea. Mil Med (2009) 0.98

Tolerability and pharmacokinetics of avanafil, a phosphodiesterase type 5 inhibitor: a single- and multiple-dose, double-blind, randomized, placebo-controlled, dose-escalation study in healthy Korean male volunteers. Clin Ther (2010) 0.97

YC-1 induces S cell cycle arrest and apoptosis by activating checkpoint kinases. Cancer Res (2006) 0.97

Environmental factors associated with larval habitats of malaria vectors in northern Kyunggi Province, Republic of Korea. J Am Mosq Control Assoc (2002) 0.96

Identification and prevalence of Ehrlichia chaffeensis infection in Haemaphysalis longicornis ticks from Korea by PCR, sequencing and phylogenetic analysis based on 16S rRNA gene. J Vet Sci (2005) 0.96

Genetic polymorphisms of drug-metabolizing enzymes and anti-TB drug-induced hepatitis. Pharmacogenomics (2009) 0.96

Gastroprotective action of Cochinchina momordica seed extract is mediated by activation of CGRP and inhibition of cPLA(2)/5-LOX pathway. Dig Dis Sci (2009) 0.96

Validation of ecological niche models for potential malaria vectors in the Republic of Korea. J Am Mosq Control Assoc (2010) 0.96

Genetic diversity and natural selection of Duffy binding protein of Plasmodium vivax Korean isolates. Acta Trop (2012) 0.95

Genetic polymorphisms of SULT1A1 and SULT1E1 and the risk and survival of breast cancer. Cancer Epidemiol Biomarkers Prev (2005) 0.95

Malaria risk assessment for the Republic of Korea based on models of mosquito distribution. US Army Med Dep J (2010) 0.95

Seasonal distribution, biology, and human attraction patterns of culicine mosquitoes (Diptera: Culicidae) in a forest near Puerto Almendras, Iquitos, Peru. J Med Entomol (2004) 0.95

Tolerability and pharmacokinetics of lobeglitazone (CKD-501), a peroxisome proliferator-activated receptor-γ agonist: a single- and multiple-dose, double-blind, randomized control study in healthy male Korean subjects. Clin Ther (2011) 0.95

Modeling the distribution of Culex tritaeniorhynchus to predict Japanese encephalitis distribution in the Republic of Korea. Geospat Health (2010) 0.94